Overview
A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
Background
A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
Indication
For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.
Associated Conditions
- Diarrhea (Dysentery)
- Infectious diarrhea
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/02/12 | Phase 1 | Completed | Liaocheng People's Hospital | ||
2025/01/16 | Early Phase 1 | Not yet recruiting | |||
2023/12/13 | Phase 4 | Recruiting | Yongquan Shi | ||
2023/02/08 | Phase 4 | Recruiting | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
2021/11/26 | Phase 4 | UNKNOWN | Shandong University | ||
2021/06/01 | Phase 4 | UNKNOWN | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
2020/12/22 | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | ||
2020/02/11 | Phase 4 | UNKNOWN | Shandong University | ||
2018/10/23 | Phase 4 | Completed | Shandong University | ||
2018/08/01 | Phase 4 | Completed | Xijing Hospital of Digestive Diseases |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Furazolidone Tablets | 国药准字H36021011 | 化学药品 | 片剂 | 7/8/2021 | |
| Furazolidone Tablets | 国药准字H37022684 | 化学药品 | 片剂 | 3/31/2021 | |
| Furazolidone Tablets | 国药准字H13020824 | 化学药品 | 片剂 | 6/30/2020 | |
| Furazolidone Tablets | 国药准字H62020471 | 化学药品 | 片剂 | 3/11/2021 | |
| Furazolidone Tablets | 国药准字H22021042 | 化学药品 | 片剂 | 3/23/2020 | |
| Furazolidone Tablets | 国药准字H46020055 | 化学药品 | 片剂 | 5/20/2020 | |
| Furazolidone Tablets | 国药准字H20065790 | 化学药品 | 片剂 | 12/1/2022 | |
| Furazolidone Tablets | 国药准字H20054079 | 化学药品 | 片剂 | 4/16/2020 | |
| Furazolidone Tablets | 国药准字H44021136 | 化学药品 | 片剂 | 8/12/2020 | |
| Furazolidone Tablets | 国药准字H44023730 | 化学药品 | 片剂 | 4/7/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| LOMOFEN Tablets | 20437 | Proqualix Pty Ltd - in Administration | Medicine | A | 9/27/1991 |